BCI Pharma was founded in March 2013 by Dominique Surleraux and Dr Elisabeth Picou. Backed by molecular modelling, the company designed and developed novel molecules/compounds that can inhibit target kinases with very high selectivity, thereby improving the safety and tolerability profile of patients.
Related articlePharmaceutical Giant Gedeon Richter Unveils its New Headquarters in Budapest
Gedeon Richter Plc., based in Budapest, Hungary, is a major pharmaceutical company in Central…
Read More…
Source: https://hungarytoday.hu/pharmaceutical-giant-richter-acquires-belgium-based-biotech-company/